These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Scaffold and edge vascular response following implantation of everolimus-eluting bioresorbable vascular scaffold: a 3-year serial optical coherence tomography study. Zhang YJ; Iqbal J; Nakatani S; Bourantas CV; Campos CM; Ishibashi Y; Cho YK; Veldhof S; Wang J; Onuma Y; Garcia-Garcia HM; Dudek D; van Geuns RJ; Serruys PW; JACC Cardiovasc Interv; 2014 Dec; 7(12):1361-9. PubMed ID: 25457053 [TBL] [Abstract][Full Text] [Related]
43. OCT-assessment of scaffold resorption: Analysis of strut intensity by a new resorption index for poly-l-lactic acid bioresorbable vascular scaffolds. Blachutzik F; Achenbach S; Marwan M; Tröbs M; Boeder N; Doerr O; Weissner M; Bauer T; Nef H; Hamm C; Schlundt C Catheter Cardiovasc Interv; 2019 Dec; 94(7):928-935. PubMed ID: 30945432 [TBL] [Abstract][Full Text] [Related]
44. Different vascular healing process between bioabsorbable polymer-coated everolimus-eluting stents versus bioresorbable vascular scaffolds via optical coherence tomography and coronary angioscopy (the ENHANCE study: ENdothelial Healing Assessment with Novel Coronary tEchnology). Wan Ahmad WA; Nakayoshi T; Mahmood Zuhdi AS; Ismail MD; Zainal Abidin I; Ino Y; Kubo T; Akasaka T; Fukumoto Y; Ueno T Heart Vessels; 2020 Apr; 35(4):463-473. PubMed ID: 31587103 [TBL] [Abstract][Full Text] [Related]
45. Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trial. Kallinikou Z; Arroyo D; Togni M; Lehman S; Corpataux N; Cook M; Müller O; Baeriswyl G; Stauffer JC; Goy JJ; Puricel SG; Cook S Swiss Med Wkly; 2016; 146():w14274. PubMed ID: 26766027 [TBL] [Abstract][Full Text] [Related]
54. Randomized Comparison of Optical Coherence Tomography Versus Angiography to Guide Bioresorbable Vascular Scaffold Implantation: The OPTICO BVS Study. Ueki Y; Yamaji K; Barbato E; Nef H; Brugaletta S; Alfonso F; Hill J; Cook S; Burzotta F; Karagiannis A; Windecker S; Räber L Cardiovasc Revasc Med; 2020 Oct; 21(10):1244-1250. PubMed ID: 32205067 [TBL] [Abstract][Full Text] [Related]
55. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions. Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155 [TBL] [Abstract][Full Text] [Related]
56. Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent. Onuma Y; Serruys PW; Gomez J; de Bruyne B; Dudek D; Thuesen L; Smits P; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia H; Ormiston JA; Catheter Cardiovasc Interv; 2011 Jul; 78(1):3-12. PubMed ID: 21413120 [TBL] [Abstract][Full Text] [Related]
57. Are BVS suitable for ACS patients? Support from a large single center real live registry. Felix CM; Onuma Y; Fam JM; Diletti R; Ishibashi Y; Karanasos A; Everaert BRC; van Mieghem NMDA; Daemen J; de Jaegere PPT; Zijlstra F; Regar ES; van Geuns RJM Int J Cardiol; 2016 Sep; 218():89-97. PubMed ID: 27232918 [TBL] [Abstract][Full Text] [Related]
58. Bioresorbable vascular scaffolds in coronary chronic total occlusions: clinical, vasomotor and optical coherence tomography findings at three-year follow-up (ABSORB-CTO study). Gheorghe L; Millán X; Jimenez-Kockar M; Gomez-Lara J; Arzamendi D; Danduch L; Agudelo V; Serra A EuroIntervention; 2019 May; 15(1):99-107. PubMed ID: 30277460 [TBL] [Abstract][Full Text] [Related]
59. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience. Karanasos A; Van Mieghem N; van Ditzhuijzen N; Felix C; Daemen J; Autar A; Onuma Y; Kurata M; Diletti R; Valgimigli M; Kauer F; van Beusekom H; de Jaegere P; Zijlstra F; van Geuns RJ; Regar E Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969547 [TBL] [Abstract][Full Text] [Related]
60. Magnesium versus poly-L-lactic acid bioresorbable scaffolds: in vivo optical coherence tomography comparison of mechanical performance. Abellás-Sequeiros RA; Ocaranza-Sanchez R; Galvaõ-Braga C; Marques J; Gonzalez-Juanatey C Arch Cardiol Mex; 2020; 90(1):8-15. PubMed ID: 31996867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]